Matthew J. Price, MD

Biology of the Vulnerable Plaque: Part I

06/19/2008

While in stable angina, static coronary luminal narrowing by atherosclerotic plaque and dynamic vasoconstriction lead to limitation in coronary blood flow during stress, in the acute coronary syndromes, it is believed that the central...

While in stable angina, static...

06/19/2008

Cath Lab Digest

Emerging Concepts in the Response to Antiplatelet Therapy

06/19/2008

Matthew J. Price , MD;

However, luminal thrombosis after coronary plaque rupture is the proximate cause of acute coronary syndromes (unstable angina, non-ST elevation myocardial infarction, and ST-elevation myocardial infarction). Coronary thrombosis is also as an...

However, luminal thrombosis...

06/19/2008

Cath Lab Digest

Feature

Biology of the Vulnerable Plaque: Part I

06/19/2008

Matthew J. Price , MD;

Prediman K. Shah , MD, FACC;

While in stable angina, static...

06/19/2008

Cath Lab Digest

Feature

Emerging Concepts in the Response to Antiplatelet Therapy

06/19/2008

Matthew J. Price , MD;

However, luminal thrombosis...

06/19/2008

Cath Lab Digest

Original Contribution

Longer-Term Outcomes of Paclitaxel Stent Implantation (Full Title Below)

05/06/2010

Wisam Shaba , MD;

Curtiss P. Stinis , MD;

Latrice Miller , BA;

Paul S. Teirstein , MD, FACC;

Matthew J. Price , MD;

Justin P. Levisay , MD;

Steven S. Lee , MD;

Longer-Term Outcomes of Paclitaxel Stent Implantation as an Initial Treatment Strategy for Sirolimus-Eluting Stent Restenosis ABSTRACT: Objective. The goal of this study was to determine the long-term clinical outcomes after an initial...

Longer-Term Outcomes of...

05/06/2010

Journal of Invasive Cardiology

Clinical Update

Testing for Clopidogrel Non-Responsiveness in the PCI Patient

09/14/2009

Matthew J. Price , MD;

What does “platelet resistance” mean? A better term to use would be clopidogrel non-responsiveness, or, even more specifically, high platelet reactivity while on clopidogrel (Plavix) therapy. Clopidogrel exerts its anti-platelet effect by...

What does “platelet resistance”...

09/14/2009

Cath Lab Digest

Clinical Editor's Corner

A Relook at the Transseptal Puncture: Heparin Dosing and Other Top Tips

11/05/2017

Jeffrey W. Moses , MD;

Zoltan G. Turi , MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Jonathan M. Tobis , MD;

Matthew J. Price , MD;

Chet Rihal ;

Given the infrequency with which we perform TSP, I asked my expert cath lab colleagues about the need for more heparin in TSP for only diagnostic purposes. In addition, I also asked, “Does the anticoagulation regimen differ for each type of...

Given the infrequency with which...

11/05/2017

Cath Lab Digest

Clinical Editor's Corner

Conversations in Cardiology: Do We Need to Document Balloon Inflation Pressures?

04/20/2023

Lloyd W. Klein , MD;

James C. Blankenship , MD;

Neal S. Kleiman , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Mitchell W. Krucoff , MD;

Ken Rosenfeld , MD;

Samuel M. Butman , MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

David A. Cox , MD;

Jeffrey W. Moses , MD;

Prashant Kaul , MD, FACC, FSCAI;

Barry F. Uretsky , MD;

Matthew J. Price , MD;

Mauricio G. Cohen , MD, FACC;

Chet Rihal ;

Gurpreet S. Sandhu , MD, PhD;

Mr. Phillip Mumford asked, “We are changing our patient documentation to Epic at my facilities. Do you know if it’s required to still document balloon inflation pressures (ATM) and time (seconds) when charting the procedure?"

Mr. Phillip Mumford asked, “We...

04/20/2023

Cath Lab Digest

A Multicenter, Randomized, Dose-Finding Study of Gamma Intracoronary Radiation Therapy to Inhibit Recurrent Restenosis after Ste

08/01/2008

Roberto Lipsztein , MD;

Prabhakar Tripuraneni , MD;

Paul S. Teirstein , MD, FACC;

Martin B. Leon , MD;

Alexandra J. Lansky , MD;

Manuela Negoita , MD;

Huan Giap , MD;

Ray Lin , MD;

Stephen Balter , PhD;

Roxana Mehran , MD;

Shirish Jani , PhD;

Matthew J. Price , MD;

Jeffrey W. Moses , MD;

Stephen Steuterman , MS;

Michael B. Collins , MD;

Jack Dalton , MD;

Intracoronary radiation therapy (ICRT) for in-stent restenosis within bare metal stents substantially reduces the risk of recurrence.1–3 However, target vessel failure remains a significant clinical problem for some patients. A higher...

Intracoronary radiation therapy...

08/01/2008

Journal of Invasive Cardiology